|Module 1 of this MasterClass has been postponed to October 2020. Dates for module 2 are still being confirmed. If you have any queries please do not hesitate to contact us.|
These courses are for neurologists who are currently prescribing, experienced MS nurses, final year registrars and pharmacists who may be working in a unit that prescribes MS therapies who want to increase or update their knowledge & belong to a network of MSologists.
The course will advance understanding of MS through taught sessions and mentorship (a mentor will be appointed for each participant if required).
MS Intermediate MasterClass 11 will be awarded CPD accreditation from the Royal College of Physicians of the United Kingdom upon completion of Module 2. The 2019 MasterClass was approved for 30 category 1 (external) CPD credit(s). Full conditions of approval are listed in our guidelines. 12 External credits may be claimed for an MSc or equivalent activity.
Module 2: Dates TBC, Sheffield
To complete the course delegates must return for Module 2 where they will present their inter-module project/audit to the Academy. → Click here for Module 2
The course is fully funded including a travel allowance for clinicians practising in the UK for both modules. There will be a £100 deposit required to secure your place, this will be invoiced to you upon confirmation. This deposit will be refunded within 30 days of you completing both modules of the course. Failure to attend or if you should cancel less than 8 weeks of the course commencement date this will result in the charge of £100.
Register your interest in a future course
This MasterClass is fully booked now, please click on the button below to register your interest for our next MS Intermediate MasterClass.
Places are confirmed on a first come basis following receipt of the completed application form. A pre-course needs assessment will need to be completed to ensure the course is adapted for each individuals needs. This will be sent to you upon confirmation.
→ Please read our terms & conditions.
This activity has been supported by sponsorship from Roche Products Limited, Biogen Idec Limited and Sanofi Genzyme. The sponsors have had no control over the educational content of this activity.